176 related articles for article (PubMed ID: 32021345)
1. Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes.
Zhang C; Ou Q; Gu Y; Cheng G; Du R; Yuan L; Cordiner RL; Kang D; Zhang J; Huang Q; Yu C; Kang L; Wang X; Sun X; Mo X; Tian H; Pearson ER; Meng W; Li S
Diabetes Metab Syndr Obes; 2019; 12():2819-2828. PubMed ID: 32021345
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia.
Kidd L; Geddings J; Hisada Y; Sueda M; Concannon T; Nichols T; Merricks E; Mackman N
J Vet Intern Med; 2015; 29(3):908-16. PubMed ID: 25871966
[TBL] [Abstract][Full Text] [Related]
3. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
[TBL] [Abstract][Full Text] [Related]
4. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P
Platelets; 2019; 30(3):348-355. PubMed ID: 29547014
[TBL] [Abstract][Full Text] [Related]
5. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.
Van Der Meijden PE; Van Schilfgaarde M; Van Oerle R; Renné T; ten Cate H; Spronk HM
J Thromb Haemost; 2012 Jul; 10(7):1355-62. PubMed ID: 22537188
[TBL] [Abstract][Full Text] [Related]
6. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy.
Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC
J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407
[TBL] [Abstract][Full Text] [Related]
7. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
8. Microparticles in hemostasis and thrombosis.
Owens AP; Mackman N
Circ Res; 2011 May; 108(10):1284-97. PubMed ID: 21566224
[TBL] [Abstract][Full Text] [Related]
9. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
[TBL] [Abstract][Full Text] [Related]
10. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
11. Procoagulant Activity of Blood and Endothelial Cells via Phosphatidylserine Exposure and Microparticle Delivery in Patients with Diabetic Retinopathy.
Su Y; Chen J; Dong Z; Zhang Y; Ma R; Kou J; Wang F; Shi J
Cell Physiol Biochem; 2018; 45(6):2411-2420. PubMed ID: 29554658
[TBL] [Abstract][Full Text] [Related]
12. Intravascular cells and circulating microparticles induce procoagulant activity via phosphatidylserine exposure in heart failure.
Kou Y; Zou L; Liu R; Zhao X; Wang Y; Zhang C; Dong Z; Kou J; Bi Y; Fu L; Shi J
J Thromb Thrombolysis; 2019 Aug; 48(2):187-194. PubMed ID: 31177487
[TBL] [Abstract][Full Text] [Related]
13. Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss.
Patil R; Ghosh K; Satoskar P; Shetty S
PLoS One; 2013; 8(11):e81407. PubMed ID: 24278436
[TBL] [Abstract][Full Text] [Related]
14. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.
Almquist T; Mobarrez F; Jacobson SH; Wallén H; Hjemdahl P
Nephrol Dial Transplant; 2016 Jun; 31(6):944-52. PubMed ID: 26394646
[TBL] [Abstract][Full Text] [Related]
15. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
16. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
17. Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.
Wang L; Bi Y; Cao M; Ma R; Wu X; Zhang Y; Ding W; Liu Y; Yu Q; Zhang Y; Jiang H; Sun Y; Tong D; Guo L; Dong Z; Tian Y; Kou J; Shi J
Int J Cardiol; 2016 Nov; 223():121-128. PubMed ID: 27537737
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
Zhao L; Bi Y; Kou J; Shi J; Piao D
J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
[TBL] [Abstract][Full Text] [Related]
19. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylserine on microparticles and associated cells contributes to the hypercoagulable state in diabetic kidney disease.
Yu M; Xie R; Zhang Y; Liang H; Hou L; Yu C; Zhang J; Dong Z; Tian Y; Bi Y; Kou J; Novakovic VA; Shi J
Nephrol Dial Transplant; 2018 Dec; 33(12):2115-2127. PubMed ID: 29529237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
